
Google’s answer to enabling third-party payment options in the Google Play Store — User Choice Billing — is now being piloted in more countries to let developers of non-gaming Android apps test offering payment alternatives.
Developers will see the typical 15% to 30% service fee charged by Google drop by 4% when users opt to use a third-party billing option, according to multiple media outlets on Friday (Sept. 2). App developers who go that route will then have to deal with customer billing disputes.
Registered developers from the European Economic Area (EEA), India, Japan, Indonesia and Australia can participate in User Choice Billing as of Thursday (Sept. 1), according to Google’s enrollment page.
“Android has always been a uniquely open operating system and we continue to evolve our platform and increase the choices available to developers and users while maintaining our ability to invest in the ecosystem,” a Google spokesperson said.
“With this next phase of Google Play’s user choice billing pilot, all non-gaming developers can offer an additional billing choice alongside Play’s billing system for their users in Australia, Japan, India, Indonesia, and the European Economic Area. We will be sharing more in the coming months as we continue to build and iterate with our pilot partners,” the spokesperson said.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Fortnite Returns to Apple’s U.S. App Store After Five-Year Ban
May 21, 2025 by
CPI
Federal Court to Hear Case on Trump’s Firing of FTC Democrats
May 20, 2025 by
CPI
UK Government Suffers Third Successive Defeat on Data (Use and Access) Bill
May 20, 2025 by
CPI
Sex Toy Retailer Says Google Breaches EU Digital Market Rules
May 20, 2025 by
CPI
Latham & Watkins Expands Brussels Antitrust Team
May 20, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas